Recruiting Phase 1 2025-522904-26-00

Clinical Study to Evaluate the Effects of Cevostamab in Patients with Lupus with or without Active Lupus Nephritis

Phase 1 – testing safety in a small group of people

Conditions: Systemic Lupus Erythematosus (SLE) With or Without Active Lupus Nephritis (LN)

Sponsor: Genentech Inc.

trial.available_in:

БГ

Overview

Trial status: Authorised

Who can participate

Age group: 18-64 years, 65+ years Gender: Female, Male Target enrollment: 10 participants

France (1)

Italy (1)

Status

Recruiting

Phase

Phase 1

Study type

INTERVENTIONAL

Sex

Male and female

Minimum age

18 Years

Healthy volunteers

Start date

22.04.2026

Registry ID

2025-522904-26-00

Source

euclinicaltrials.eu

Information is automatically extracted from ClinicalTrials.gov. Consult your doctor before taking action.